Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Clinical Genitourinary Cancer
|
January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin
Mehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Acta Pharmaceutica Sinica. B
|
October 24, 2025
Dissecting the effects of <sup>223</sup>Radium on the bone microenvironment
Sergio Barrios, Elisa Serafini, Ludovica La Posta, et al.
Prostate Cancer and Prostatic Diseases
|
December 26, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment
Paul G Corn, Guoyu Yu, Yibo Fan, et al.
Cancer Research
|
February 24, 2025
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
Yuehui Zhao, Naveen Ramesh, Ping Xu, et al.
Cancers
|
July 27, 2024
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice
Song-Chang Lin, Guoyu Yu, Paul G Corn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2014
Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen
Maha Hussain, Paul G Corn, M Dror Michaelson, et al.
BJU International
|
June 3, 2015
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases
Sarathi Kalra, Bradley J Atkinson, Marc Ryan Matrana, et al.
Nature Communications
|
June 1, 2016
CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
Tao Zhang, Chieh Tseng, Yan Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 2020
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer
Bridget F Koontz, Karen E Hoffman, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma
Eric Jonasch, Christopher G Wood, Surena F Matin, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Clinical Genitourinary Cancer
|
January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin
Mehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Acta Pharmaceutica Sinica. B
|
October 24, 2025
Dissecting the effects of <sup>223</sup>Radium on the bone microenvironment
Sergio Barrios, Elisa Serafini, Ludovica La Posta, et al.
Prostate Cancer and Prostatic Diseases
|
December 26, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironment
Paul G Corn, Guoyu Yu, Yibo Fan, et al.
Cancer Research
|
February 24, 2025
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
Yuehui Zhao, Naveen Ramesh, Ping Xu, et al.
Cancers
|
July 27, 2024
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice
Song-Chang Lin, Guoyu Yu, Paul G Corn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2014
Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen
Maha Hussain, Paul G Corn, M Dror Michaelson, et al.
BJU International
|
June 3, 2015
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases
Sarathi Kalra, Bradley J Atkinson, Marc Ryan Matrana, et al.
Nature Communications
|
June 1, 2016
CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
Tao Zhang, Chieh Tseng, Yan Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 2020
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer
Bridget F Koontz, Karen E Hoffman, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma
Eric Jonasch, Christopher G Wood, Surena F Matin, et al.
Page
of 10